VERIPURE

Welcome to the Brand page for “VERIPURE”, which is offered here for Medicinal and pharmaceutical preparations, pharmaceutical medications for the treatment and prevention of tumors; medicinal and pharmaceutical preparations, pharmaceutical medications for the treatment and prevention of solid tumors, melanoma, breast cancer, basal cell carcinoma, prostate cancer, and small cell and non-small cell lung cancer, squamous cell carcinoma and primary and metastatic liver cancers; medicinal and pharmaceutical preparations, pharmaceutical medications for the treatment and prevention of pediatric solid tumors, ewing sarcoma, neuroblastoma, osteosarcoma, neuroepithelioma, and rhabdomyosarcoma; medicinal and pharmaceutical preparations, pharmaceutical medications for the treatment and prevention of leukemia; medicinal and pharmaceutical preparations, pharmaceutical medications for the treatment and prevention of leukemia, acute b-cell lymphoblastic leukemia, t-cell lymphoblastic leukemia, acute myeloid leukemia; medicinal and pharmaceutical preparations, pharmaceutical medications for the treatment and prevention of psoriasis; preparations for pharmaceutical skin care; diagnostic mediums for use in virology, microbiology, ophthalmology; pharmaceutical preparations and substances for use as vaccine adjuvants, immune system stimulators or suppressors, and immune system modulators;.

Its status is currently believed to be active. Its class is unavailable. “VERIPURE” is believed to be currently owned by “Provectus Pharmatech, Inc.”